Physician profile
Stacey Lenell Holmes
NPI 1801664271
$2,355.73
in general payments reported to CMS, 2019-2025
15 companies · $75.97 in 2025
The $75.97 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,280 · 2025: $75.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,238 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,238.08 |
| Education | $117.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $477.26 | 2024 | Caplyta |
| Abbvie INC. | $324.29 | 2024-2025 | |
| Alkermes, INC. | $270.71 | 2024-2025 | Aristada, Lybalvi |
| Otsuka America Pharmaceutical, INC. | $258.37 | 2024 | Rexulti, Abilify Asimtufii |
| Neurocrine Biosciences, INC. | $213.20 | 2024 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $211.50 | 2024 | Uzedy, Austedo Xr |
| Almatica Pharma LLC | $151.26 | 2024 | Loreev Xr |
| Axsome Therapeutics, INC. | $105.42 | 2024 | Auvelity |
| Idorsia Pharmaceuticals US INC | $79.46 | 2024 | Quviviq |
| Vanda Pharmaceuticals INC. | $71.65 | 2024 | Fanapt, Hetlioz |
| E.R. Squibb & Sons, L.L.C. | $63.33 | 2024-2025 | Cobenfy |
| Janssen Pharmaceuticals, INC | $38.53 | 2024 | Invega Sustenna, Invega Trinza |
| Indivior INC. | $37.93 | 2024 | Perseris |
| Noven Therapeutics, LLC | $28.37 | 2024 | Secuado, Xelstrym |
| Lundbeck LLC | $24.45 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.